NASDAQ, VICL - Vical Incorporated
We research and develop biopharmaceutical products based on our patented DNA
delivery technologies for the prevention and treatment of serious or
life-threatening diseases. We believe the following areas of research offer the
greatest potential for our product development efforts:
? Vaccines for use in high-risk populations for infectious disease targets
for which there are significant U.S. needs;
? Vaccines for general pediatric, adolescent and adult populations for
infectious disease applications; and
? Cancer vaccines or immunotherapies which complement our existing programs
and core expertise. ...
Read SEC Filing on NASDAQ.com »